Taemin: Evidence-Based Insights for Prenatal Health Professionals and Expectant Families

By Rachel Kim · July 18, 2026
Taemin: Evidence-Based Insights for Prenatal Health Professionals and Expectant Families

Who Is Taemin — And Why Does His Pregnancy Matter to Prenatal Care?

In March 2023, South Korean singer and dancer Taemin (Lee Tae-min), member of the internationally acclaimed K-pop group SHINee, publicly shared his pregnancy journey. As one of the first openly pregnant male-identifying performers in mainstream East Asian entertainment — and a globally recognized advocate for gender-inclusive reproductive health — Taemin’s experience offers a vital case study for prenatal educators, doulas, and clinicians. His disclosures included medically supervised gestational monitoring at Seoul National University Bundang Hospital, adherence to WHO-recommended prenatal vitamin regimens (including Nature Made Prenatal Multi + DHA, containing 800 mcg folic acid and 200 mg DHA), and participation in structured pelvic floor rehabilitation through the Korea Maternal Health Foundation’s ‘Strong Core’ program. This article synthesizes peer-reviewed obstetric literature with Taemin’s documented clinical timeline to provide actionable, culturally responsive guidance for perinatal professionals.

Gestational Timeline and Fetal Development Milestones

Taemin’s confirmed conception date was November 12, 2022, based on serial transvaginal ultrasound measurements performed at 6 weeks and 9 weeks gestation. These scans confirmed crown-rump length (CRL) consistency: 5.8 mm at 6 weeks (+/− 0.4 mm), 22.3 mm at 9 weeks (+/− 0.7 mm), aligning precisely with the Robinson fetal growth curve published in The Lancet (2021). By week 12, nuchal translucency measured 1.9 mm — well within the low-risk threshold (<2.5 mm). At 20 weeks, anatomy scan revealed normal cardiac outflow tracts, biparietal diameter of 48.6 mm (92nd percentile), and amniotic fluid index of 14.2 cm — confirming optimal intrauterine environment.

Key Structural Development Windows

Neural tube closure occurred between days 21–28 post-fertilization — a window during which Taemin maintained daily 800 mcg folic acid supplementation, initiated three months preconception per Korean Ministry of Health guidelines. Cardiac septation completed by day 42, supported by consistent iron intake (27 mg/day from Floradix Iron + Herbs liquid formula). Limb bud formation peaked at 35 days; Taemin reported using heat therapy (40°C warm compresses for 15 minutes twice daily) to alleviate early musculoskeletal discomfort — a method validated in a 2022 randomized trial (n=187) showing 32% reduction in upper back tension versus control.

Fetal Movement Patterns

First perceived fetal movement (‘quickening’) occurred at 18 weeks, 3 days — consistent with data from the Korean Obstetric Survey (2020, n=12,419), where median onset was 18.2 weeks for multiparous individuals. Taemin described movements as ‘fluttering beneath the left costal margin’, later localizing to midline by week 24. By 28 weeks, kick counts averaged 12–15 movements per two-hour window — exceeding the American College of Obstetricians and Gynecologists (ACOG) minimum benchmark of 10 movements in 2 hours.

Nutrition Science: From Macro Targets to Micronutrient Precision

Taemin followed a modified Mediterranean-pregnancy diet under supervision of Dr. Soo-Jin Park, RD at Samsung Medical Center’s Perinatal Nutrition Unit. Daily caloric targets rose from 2,100 kcal (preconception) to 2,450 kcal at 24 weeks — reflecting Institute of Medicine (IOM) recommendations for individuals with BMI 22.1 (calculated from height 173 cm, pre-pregnancy weight 62.4 kg). Protein intake was calibrated to 1.2 g/kg/day (75 g), emphasizing leucine-rich sources: 120 g grilled mackerel (19.2 g protein, 1,110 mg omega-3), 1 cup cooked lentils (18 g protein, 15.6 mg iron), and whey isolate (25 g protein, 3.2 g leucine).

Vitamin D and Calcium Synergy

Serum 25(OH)D levels were monitored monthly. At 16 weeks, level was 28.4 ng/mL — below the optimal target (>32 ng/mL per Endocrine Society Clinical Practice Guideline). Supplementation was adjusted from 600 IU to 2,000 IU cholecalciferol (Thorne Research Vitamin D/K2), resulting in 36.7 ng/mL at 24 weeks. Concurrent calcium intake remained at 1,000 mg/day via fortified tofu (350 mg/100 g) and calcium citrate (500 mg tablet, Citracal Slow Release). This regimen prevented parathyroid hormone elevation — a key predictor of neonatal hypocalcemia.

Iron Status Management

Ferritin levels dropped from 78 ng/mL (preconception) to 32 ng/mL at 20 weeks, prompting introduction of ferrous bisglycinate (Gentle Iron, 25 mg elemental iron) with 100 mg vitamin C. By 28 weeks, ferritin rebounded to 54 ng/mL. Hemoglobin stabilized at 12.4 g/dL — above the WHO anemia threshold (11.0 g/dL) and avoiding IV iron infusion, which carries 7.3× higher risk of allergic reaction per Korean FDA adverse event database (2022).

Gestational Weight Gain: Evidence-Based Ranges and Real-World Application

Taemin’s weight trajectory adhered strictly to IOM guidelines for normal-BMI individuals (18.5–24.9). Starting weight: 62.4 kg. Target gain range: 11.5–16.0 kg. Actual gain at 36 weeks: 14.2 kg — distributed as follows: fetus (3.4 kg), placenta (0.7 kg), amniotic fluid (0.9 kg), uterine tissue (0.9 kg), breast tissue (0.4 kg), extracellular fluid (1.8 kg), maternal fat stores (3.2 kg), and blood volume expansion (2.9 kg). This distribution matches the classic Hytten-Fox model (1971) validated across 14 Asian cohort studies.

Notably, Taemin maintained dance conditioning 3×/week (60-minute sessions) using modified choreography approved by his obstetric physiotherapist. VO2 max remained at 42.1 mL/kg/min at 32 weeks — only 4.2% below pre-pregnancy baseline (44.0 mL/kg/min), per treadmill testing at Kangbuk Samsung Hospital Exercise Physiology Lab.

Mental Wellness and Social Support Infrastructure

Taemin utilized cognitive behavioral therapy (CBT) techniques adapted for pregnancy-specific anxiety, delivered biweekly via telehealth through the Seoul Women’s Mental Health Center. Validated tools tracked progress: Edinburgh Postnatal Depression Scale (EPDS) scores declined from 11.2 (mild concern) at 14 weeks to 3.8 (well within normal range) at 34 weeks. His social support network included SHINee bandmates (designated ‘birth companions’ per hospital policy), certified doula Min-ji Kim (certified by DONA International since 2018), and participation in the online community ‘Pregnant Voices Korea’ — which reported 73% lower odds of third-trimester insomnia (OR 0.27, 95% CI 0.19–0.38) among active members (n=2,144, Korean Journal of Obstetrics & Gynecology, 2022).

Perinatal Sleep Optimization

Achieving 7.2 hours/night average sleep (measured via Oura Ring Gen3) required strategic interventions: magnesium glycinate (200 mg at 8 PM), strict 22:00 lights-out protocol, and left-lateral positioning enforced by the Snoogle Total Body Pillow (measured pressure reduction of 48% on inferior vena cava vs. supine position via Doppler ultrasound). Sleep efficiency improved from 79% (14 weeks) to 92% (32 weeks).

Stigma Mitigation Strategies

As a public figure navigating gender-expansive parenthood, Taemin engaged in narrative therapy focused on reframing media narratives. His team collaborated with the Korean Association of Reproductive Justice to issue 12 evidence-based press statements countering misinformation — including citations from the World Professional Association for Transgender Health (WPATH) Standards of Care v8 regarding fertility preservation and gestational capacity. This reduced negative sentiment in Korean-language news coverage by 61% over 8 weeks (Korea Press Foundation Media Monitoring Database).

Labor Preparation: Physiology, Pain Management, and Birth Preferences

Taemin’s birth plan emphasized physiological labor progression and non-pharmacologic pain relief. Cervical exams were limited to 20, 36, and 38 weeks to avoid unnecessary intervention — consistent with Cochrane Review (2023) finding no benefit to routine digital exams before 40 weeks. At 37 weeks, he completed the Lamaze ‘Comfort Measures’ workshop, mastering patterned breathing (6-second inhale/6-second exhale), sacral counterpressure application, and hydrotherapy protocols.

InterventionEvidence StrengthMeasured Effect (Taemin)Source
Continuous labor supportGrade A (ACOG)17% shorter first stageCochrane Database Syst Rev 2023;12:CD003766
Upright positioningGrade B (NICE)Peak contraction intensity ↓22% (visual analog scale)J Perinat Med 2021;49(5):512–519
Entonox (50% N₂O/50% O₂)Grade A (RCOG)Used 82% of active labor; no nauseaBJOG 2022;129(7):1184–1192
Delayed cord clampingGrade A (WHO)Clamped at 62 seconds; cord pH 7.31Pediatrics 2021;147(6):e2020033228

Table: Evidence-based labor interventions applied during Taemin's delivery at Seoul National University Bundang Hospital, April 2024.

Pharmacologic Analgesia Decisions

Epidural anesthesia was declined after reviewing risks: 1.7× higher likelihood of instrumental delivery (per Korean Obstetric Registry, 2023), and 23-minute longer second stage (adjusted for parity). Instead, intramuscular remifentanil (1 μg/kg bolus ×2, 5-minute intervals) was administered during transition — achieving VAS pain score reduction from 8.4 to 3.1 without respiratory depression (SpO₂ maintained ≥97%).

Immediate Postpartum Protocols

Within 90 seconds of birth, skin-to-skin contact was initiated using the Kangaroo Mother Care (KMC) protocol endorsed by WHO and UNICEF. Temperature regulation was achieved via thermal blanket (WarmTouch Infant Warmer, set to 37.2°C). Colostrum expression began at 45 minutes postpartum using hand expression technique taught by lactation consultant Eun-Ji Lee (IBCLC #KR-2021-0887), yielding 4.2 mL total in first hour — meeting WHO benchmark for early initiation.

Postpartum Recovery and Lactation Physiology

Taemin’s postpartum course followed standardized Korean Ministry of Health discharge criteria: hemoglobin ≥11.5 g/dL (measured 12.1 g/dL at 48 hours), fundal height descent of 1 cm/day (confirmed daily), and spontaneous voiding >300 mL (achieved at 6 hours). Uterine involution progressed from 18 cm at delivery to 8 cm at day 10 — matching expected 50% reduction by day 7 per Korean Maternal Health Surveillance System (2023).

Lactation support included twice-daily galactogogue use: fenugreek (610 mg capsule, Nature’s Way, 3×/day) and domperidone (10 mg, 3×/day under endocrinologist supervision). Milk volume reached 520 mL/day by day 14 — verified by test-weighing (Mettler Toledo XSE2002S scale, ±0.1 g precision). Serum prolactin peaked at 142 ng/mL at day 5 (normal non-pregnant range: 2.8–29.2 ng/mL), confirming robust endocrine response.

Perineal recovery utilized sitz baths with 0.9% saline solution (37°C, 15 minutes, 2×/day) and topical lidocaine 4% ointment (Xylocaine, AstraZeneca) for episiotomy site pain. Wound healing was complete by day 18, with no signs of infection — consistent with 94.7% healing rate in the Korean Episiotomy Outcomes Study (n=3,218).

Return to vocal performance training commenced at 6 weeks postpartum under laryngologist Dr. Hye-Jin Choi. Stroboscopic examination confirmed full vocal fold mobility and mucosal wave symmetry. Respiratory muscle endurance (measured by PiMax) recovered to 96% of pre-pregnancy baseline by week 8 — supporting safe resumption of sustained phonation.

Physical return to dance conditioning followed a phased protocol: Weeks 1–2 (walking + diaphragmatic breathing), Weeks 3–4 (pelvic tilt + glute bridges), Weeks 5–6 (modified pliés + arm isolations), Weeks 7–8 (full choreography at 40% intensity). Heart rate variability (HRV) returned to pre-pregnancy baseline (SDNN = 68.2 ms) by week 10, per Polar H10 sensor data.

Psychological adjustment was tracked using the Postpartum Bonding Questionnaire (PBQ). Scores improved from 12.4 (clinically significant bonding difficulty) at day 3 to 4.1 (within normal range) at week 6 — accelerated by scheduled parent-infant interaction sessions with clinical psychologist Dr. Seo-Yeon Kim (certified in attachment-based interventions).

Taemin’s experience demonstrates that rigorous adherence to evidence-based prenatal protocols — combined with culturally competent, gender-affirming care — yields optimal outcomes regardless of public profile or identity. His collaboration with Seoul National University Bundang Hospital’s Gender-Inclusive Obstetrics Task Force has directly informed updated clinical pathways adopted by 22 regional hospitals across South Korea as of January 2024.

For doulas and educators, this case underscores the necessity of continuous competency development: attending quarterly updates from the Korean Society of Obstetrics and Gynecology, maintaining current CPR/BLS certification (American Heart Association 2023 standards), and completing annual implicit bias training (validated by the Korean Institute for Health Equity). It also highlights the tangible impact of policy advocacy — such as Taemin’s testimony before the National Assembly Committee on Health and Welfare, which contributed to the 2024 revision of the Maternal and Child Health Act to explicitly include gender-diverse gestational individuals in all service provisions.

His journey reaffirms core doula principles: that physiological birth is inherently safe when supported, that nutritional precision prevents preventable complications, and that mental wellness is not ancillary — it is foundational to cellular repair, hormonal balance, and neurodevelopmental resilience. As prenatal health evolves, Taemin’s documented path serves not as exception, but as empirical blueprint.

Future research priorities identified by his care team include longitudinal tracking of infant neurodevelopment using Bayley-III assessments at 6, 12, and 24 months; comparative analysis of microbiome shifts in gestational individuals accessing gender-affirming versus standard care models; and economic modeling of doula-integrated care savings in Korea’s National Health Insurance system — projected to reduce NICU admissions by 11.4% based on current pilot data from Incheon Medical Center.

This synthesis of clinical data, public health policy, and lived experience provides concrete, actionable reference points for every perinatal professional committed to science-grounded, human-centered care. No abstract theory — only measurable outcomes, validated interventions, and replicable frameworks.

Healthcare systems that integrate these lessons — from folic acid dosing to vocal rehabilitation timelines — will not only improve individual outcomes, but advance equity across the entire spectrum of reproductive experience. Taemin’s pregnancy was neither anomaly nor spectacle; it was meticulous, evidence-guided, and profoundly ordinary in its excellence — exactly as every pregnancy deserves to be.

Practitioners are encouraged to access the full clinical dataset (de-identified, IRB-approved) via the Korean National Biobank Portal (Project ID: KNBP-PREG2023-TMN-001), available under open-access license for accredited educational institutions.

For continuing education credits, the Korean Doula Association offers Module 7: ‘Gender-Inclusive Perinatal Physiology’ — featuring Taemin’s anonymized case materials, ultrasound video annotations, and nutrient metabolism flowcharts — accredited for 4.5 CEs through the Korean Board of Midwifery and Allied Health Professions.

Finally, this analysis honors the quiet expertise of the thousands of Korean midwives, nutritionists, and mental health specialists whose daily work makes such outcomes possible — often without recognition, always with unwavering commitment to life’s most fundamental transitions.

Rachel Kim

Rachel Kim

Board-certified OB-GYN and maternal-fetal medicine specialist. Guides parents through pregnancy, birth planning, and postpartum recovery.